The Clinical Epidemiology of Hospitalized Dengue Cases in Malaysia
NCT02510638 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 322
Last updated 2016-02-01
Summary
Dengue infection has been identified as the fastest spreading mosquito-borne viral disease by World Health Organization (WHO), which affects more than 2.5 billion people living in the subtropical and tropical regions. Malaysia is hyper-endemic with all four dengue virus serotypes circulating and responsible for the escalating number of cases over the years. As of 28 February 2015, there are 62 deaths secondary to dengue infection being reported in Malaysia; and the total number of dengue cases reported in the same period was 23,966 which is 46% higher than the same reporting period of 2014. Although dengue virus has been identified for so many years and plenty of research work has been carried out, it was proven that there are still many aspects that we are not too sure about the disease. Therefore, this multi-center, observational cohort study is designed to investigate the clinical course of hospitalized dengue infection in Malaysia. The study population of this study consists of male or female patients with dengue to be randomly sampled from hospitals in Malaysia. This study will be conducted in 2 stages whereby the 1st stage will only focus on the basic social and clinical data to describe the clinical course of dengue as general and the 2nd stage will collect the more detailed clinical and management data to describe the detailed clinical course, management and prognosis of dengue. All hospital participation in this study is voluntary, and approval will be obtained from National Institute of Health (NIH) and Medical Research Ethics Committee (MREC) prior to any recruitment.
Conditions
- Dengue Fever
Sponsors & Collaborators
-
Clinical Research Centre, Malaysia
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-09-30
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
Countries
- Malaysia
More Related Trials
-
Epidemiology Study of Malaria Transmission Intensity in Africa
NCT01190202 ·Status: COMPLETED ·Phase: NA
-
Trial of Malaria Seasonal IPTc Combined With Community Case Management
NCT01449045 ·Status: COMPLETED ·Phase: PHASE3
-
Epidemiology of Malaria in Ubon Ratchathani, Thailand
NCT02991963 ·Status: UNKNOWN
-
Population Immunity AgaiNst mosquitO-borne Diseases in Vanuatu
NCT05153018 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Targeted Mass Drug Administration for Malaria in Ethiopia
NCT04241705 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Community-based Mass Screening and Treatment for Malaria in Western Kenya
NCT02987270 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children
NCT00393679 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of High-dose Ivermectin for Reducing Malaria Transmission: A Dose Finding Study
NCT02511353 ·Status: COMPLETED ·Phase: PHASE2
-
The Synergistic Effects of Home-management and Intermittent Preventive Treatment of Malaria in Children
NCT00550160 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Recommended Antimalarial in the Democratic Republic of the Congo
NCT04618523 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Scaling up Mass Testing, Treatment and Tracking on Malaria Prevalence Among Children
NCT04167566 ·Status: COMPLETED ·Phase: NA
-
Malaria Active Epidemiology and Treatment Study
NCT01280162 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Performance of a hsRDT Versus cRDT in Reactive Case Detection of Malaria Infections
NCT03511443 ·Status: UNKNOWN ·Phase: NA
-
Ethiopia Malaria Therapeutic Efficacy Study
NCT01052584 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Amodiaquine-artesunate in Children Aged 6-59 Months With Uncomplicated P. Falciparum Malaria
NCT00425763 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Oral Activated Charcoal on Antimalarial Drug's Ability to Kill Parasites in Malian Children With Malaria
NCT01955382 ·Status: COMPLETED ·Phase: PHASE2
-
Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa
NCT02974348 ·Status: COMPLETED ·Phase: PHASE3
-
Amodiaquine+Artesunate vs. Artemether-Lumefantrine for Uncomplicated Malaria in Ghanaian Children
NCT00406146 ·Status: UNKNOWN ·Phase: PHASE3
-
RHOST-cRCT, Reactive Household-based Self-administered Treatment Against Residual Malaria Transmission
NCT02878200 ·Status: COMPLETED ·Phase: NA
-
Malaria Vaccine Safety and Immunogenicity Study in Healthy Adults
NCT02992119 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Treatment of Plasmodium Falciparum Malaria in Liberia
NCT06300970 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Artesunate-amodiaquine and Artemether-lumefantrine for the Treatment of Malaria in Cameroon
NCT04829695 ·Status: UNKNOWN ·Phase: PHASE4
-
The Role of Rapid Diagnostic Tests for Malaria for Targeting of ACTs at Community Level
NCT01907672 ·Status: COMPLETED ·Phase: PHASE4
-
Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria Elimination
NCT03576313 ·Status: COMPLETED ·Phase: PHASE3
-
Automated Microscopy Evaluation Study
NCT04558515 ·Status: COMPLETED